Overall Status

Completed (79)

Unknown status (22)

Recruiting (20)

Terminated (13)

Not yet recruiting (8)

Active, not recruiting (5)

Withdrawn (4)

Enrolling by invitation (1)

Suspended (1)

Phase

phase 2 (35)

phase 3 (28)

phase 4 (26)

n/a (22)

phase 1 (13)

phase 2/phase 3 (9)

phase 1/phase 2 (4)

early phase 1 (2)

Study Documents

Intervention Type

drug (133)

other (17)

device (11)

behavioral (7)

biological (2)

procedure (2)

diagnostic test (1)

dietary supplement (1)

Funder Type

Other (113)

Industry (25)

NIH (12)

U.S. Fed (3)

Study Type

Interventional (139)

Observational (14)

Amantadine

Showing 151 - 153 of 153

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatitis C, Chronic Trial (Amantadine sulphate (in addition to standard treatment))

Unknown status

Hepatitis C, Chronic

Amantadine sulphate (in addition to standard treatment)

(no location specified)

Aug 24, 2005

All Multiple Sclerosis Patients Trial in Tel Hashomer (Provigil)

Unknown status

All Multiple Sclerosis Patients

Provigil

Tel Hashomer, Israel

Multiple Sclerosis Center

Feb 16, 2006

Hepatitis C, Chronic Trial in Lyon Cedex (peg-interferon alfa-2b, ribavirin, amantadine)

Terminated

Hepatitis C, Chronic

peg-interferon alfa-2b
+2 more

Lyon Cedex, France

Service d'Hépato-Gastroentérologie Hopital Hotel Dieu

Jul 28, 2005